What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 7 minute read Pharma Industry News ExQor Technologies moves closer to clinical trials with brain regenerative medicine for Alzheimer’s disease ExQor Technologies advances toward clinical trials with a brain regenerative platform that could reverse Alzheimer’s damage and transform dementia care. bySoujanya RaviOctober 2, 2025